carboxy β cyclodextrin (Thermo Fisher)
Structured Review
Carboxy β Cyclodextrin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beta+cyclodextrin/beta-Cyclodextrin/pm42517677-178-0-5
Average 94 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Targeted delivery of doxorubicin via cholesteryl-modified cyclodextrin: Antitumor activity in breast, ovarian, and cervical cancer cell lines. Article Snippet: High cytotoxicity towards physiological cells and the development of drug resistance remain major challenges in anticancer therapy.. The use of drug delivery systems for doxorubicin hydrochloride (DOX⋅HCl) aims to enhance its selective accumulation in cancer cells and reduce adverse effects on normal tissues.. In this study, complexation efficiency was assessed through spectroscopic analysis and computational chemistry methods, while cytotoxicity was evaluated using in vitro assays on selected cell lines, including normal cells (CCd1079Sk) and cancerous cells (MCF-7, HeLa, and SKOV-3). Article Title: Cyclodextrin-Based Nanogels with Chemistry-Tunable Intracellular Stability and Distribution Article Snippet: Nile Blue Acrylamide (NBAAm, ≥80%) and DEGDA were purchased from Polysciences. Article Title: Fast Adhesion of Gold Nanoparticles (AuNPs) to a Surface Using Starch Hydrogels for Characterization of Biomolecules in Biosensor Applications Article Snippet: Dextrin (CID 62698; CAS 9004-53-9) Saline:Article Title: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Article Snippet: Recent studies suggest that dopamine D3 receptors (D3R) may be a therapeutic target for opioid use disorders (OUD).. This study examined the effects of the D3R partial agonist (±)VK4-40 and the D3R-selective antagonist (±)VK4-116, compared to the mu-opioid receptor antagonist naltrexone (NTX), in nonhuman primate models of OUD and antinociception.. Adult male and female (N= 4/ sex) cynomolgus monkeys were trained to self-administer oxycodone (0.003–0.1 mg/kg/injection) first under a fixed-ratio (FR) and then a progressive-ratio (PR) schedule of reinforcement during daily 1and 4-hr sessions, respectively. Synthesized:Article Title: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Article Snippet: Recent studies suggest that dopamine D3 receptors (D3R) may be a therapeutic target for opioid use disorders (OUD).. This study examined the effects of the D3R partial agonist (±)VK4-40 and the D3R-selective antagonist (±)VK4-116, compared to the mu-opioid receptor antagonist naltrexone (NTX), in nonhuman primate models of OUD and antinociception.. Adult male and female (N= 4/ sex) cynomolgus monkeys were trained to self-administer oxycodone (0.003–0.1 mg/kg/injection) first under a fixed-ratio (FR) and then a progressive-ratio (PR) schedule of reinforcement during daily 1and 4-hr sessions, respectively. Article Title: Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement. Article Snippet: .. Ms. Jianjing Cao, in the Medicinal Chemistry Section, NIDA-Intramural Research Program, synthesized (±)VK4-40 as described in Kumar et al. (2016). and dissolved it in 25 % Sterility:Article Title: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys. Article Snippet: Recent studies suggest that dopamine D3 receptors (D3R) may be a therapeutic target for opioid use disorders (OUD).. This study examined the effects of the D3R partial agonist (±)VK4-40 and the D3R-selective antagonist (±)VK4-116, compared to the mu-opioid receptor antagonist naltrexone (NTX), in nonhuman primate models of OUD and antinociception.. Adult male and female (N= 4/ sex) cynomolgus monkeys were trained to self-administer oxycodone (0.003–0.1 mg/kg/injection) first under a fixed-ratio (FR) and then a progressive-ratio (PR) schedule of reinforcement during daily 1and 4-hr sessions, respectively. Article Title: Selective dopamine D3 receptor partial agonist (±)VK4-40 reduces the reinforcing strength of d-amphetamine but not cocaine in rhesus monkeys responding under a progressive-ratio schedule of reinforcement. Article Snippet: .. Ms. Jianjing Cao, in the Medicinal Chemistry Section, NIDA-Intramural Research Program, synthesized (±)VK4-40 as described in Kumar et al. (2016). and dissolved it in 25 % Molecular Weight:Article Title: Synthesis of Biocompatible and Environmentally Nanofibrous Mats Loaded with Moxifloxacin as a Model Drug for Biomedical Applications Article Snippet: Polyvinyl alcohol (PVA) (Mw of 85,000–124,000, 99% hydrolyzed), low molecular weight chitosan 95% deacetylation degree was supported by Sigma-Aldrich (Saint Louis, MO, USA). .. |

